BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33490234)

  • 21. Prognostic nomograms to predict overall survival and cancer-specific survival in patients with pelvic chondrosarcoma.
    Chen L; Long C; Liu J; Duan X; Xiang Z
    Cancer Med; 2019 Sep; 8(12):5438-5449. PubMed ID: 31353800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishing a novel prognostic tool for Ewing sarcoma patients: Surveillance, Epidemiology, and End Results database analysis.
    Gao F; Zhou Y; Zhao R; Ren Y
    Medicine (Baltimore); 2020 Nov; 99(46):e23050. PubMed ID: 33181669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and Validation of Novel Nomograms for Predicting Specific Distant Metastatic Sites and Overall Survival of Patients With Soft Tissue Sarcoma.
    Tu Q; Hu C; Zhang H; Kong M; Peng C; Song M; Zhao C; Wang Y; Ma X
    Technol Cancer Res Treat; 2021; 20():1533033821997828. PubMed ID: 33706618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Clinical Model of Bone Angiosarcoma Patients: A Population-based Analysis of Epidemiology, Prognosis, and Treatment.
    Wang B; Chen LJ; Wang XY
    Orthop Surg; 2020 Dec; 12(6):1652-1662. PubMed ID: 32914587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic nomogram based on the lymph node metastasis indicators for patients with bladder cancer: A SEER population-based study and external validation.
    Li S; Wang Y; Hu X
    Cancer Med; 2023 Mar; 12(6):6853-6866. PubMed ID: 36479835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.
    Shi X; Xu L; Ma B; Wang S
    Sci Rep; 2020 Aug; 10(1):14143. PubMed ID: 32839498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of a nomogram to predict long-term cancer-specific survival for patients with osteosarcoma.
    Yu Y; Wang S; Liu J; Ge J; Guan H
    Sci Rep; 2023 Jun; 13(1):10230. PubMed ID: 37353555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nomogram predicts the prognosis of patients with thymic carcinoma: A population-based study using SEER data.
    Huang YY; Liu X; Liang SH; Wu LL; Ma GW
    Tumori; 2023 Jun; 109(3):282-294. PubMed ID: 35897150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment and Verification of Prognostic Nomograms for Young Women With Breast Cancer Bone Metastasis.
    Wang Z; Shao H; Xu Q; Wang Y; Ma Y; Diaty DM; Zhang J; Ye Z
    Front Med (Lausanne); 2022; 9():840024. PubMed ID: 35492327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two Novel Nomograms Predicting the Risk and Prognosis of Pancreatic Cancer Patients With Lung Metastases: A Population-Based Study.
    Zhang W; Ji L; Zhong X; Zhu S; Zhang Y; Ge M; Kang Y; Bi Q
    Front Public Health; 2022; 10():884349. PubMed ID: 35712294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer.
    Li Y; Ma L
    BMC Cancer; 2021 Aug; 21(1):965. PubMed ID: 34454451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nomogram Predicts Risk and Prognostic Factors for Bone Metastasis of Pancreatic Cancer: A Population-Based Analysis.
    Zhang W; Ji L; Wang X; Zhu S; Luo J; Zhang Y; Tong Y; Feng F; Kang Y; Bi Q
    Front Endocrinol (Lausanne); 2021; 12():752176. PubMed ID: 35356148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment and validation of a nomogram for predicting overall survival of upper-tract urothelial carcinoma with bone metastasis: a population-based study.
    Hu J; Gu H; Zhang D; Wen M; Yan Z; Song B; Xie C
    BMC Urol; 2024 Apr; 24(1):100. PubMed ID: 38689213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nomogram for predicting the overall survival and cancer-specific survival of patients with extremity liposarcoma: a population-based study.
    Ye L; Hu C; Wang C; Yu W; Liu F; Chen Z
    BMC Cancer; 2020 Sep; 20(1):889. PubMed ID: 32938431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction and validation of nomograms for predicting the prognosis of elderly patients with uterine serous carcinoma: a SEER-based study.
    Liu T; Zhang H; Han C; Kong W
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14475-14492. PubMed ID: 37567988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgery for primary tumor benefits survival for breast cancer patients with bone metastases: a large cohort retrospective study.
    Huang Z; Zhou X; Tong Y; Zhu L; Zhao R; Huang X
    BMC Cancer; 2021 Mar; 21(1):222. PubMed ID: 33663462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment and validation of nomograms for predicting survival of lung invasive adenocarcinoma based on the level of pathological differentiation: a SEER cohort-based analysis.
    Wang X; Xu Y; Xu J; Chen Y; Song C; Jiang G; Chen R; Mao W; Zheng M; Wan Y
    Transl Cancer Res; 2023 Apr; 12(4):804-827. PubMed ID: 37180650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nomograms to predict survival after colorectal cancer resection without preoperative therapy.
    Zhang ZY; Luo QF; Yin XW; Dai ZL; Basnet S; Ge HY
    BMC Cancer; 2016 Aug; 16(1):658. PubMed ID: 27553083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A New Online Dynamic Nomogram: Construction and Validation of a Predictive Model for Distant Metastasis Risk and Prognosis in Patients with Gastrointestinal Stromal Tumors.
    Wu H; Ding P; Wu J; Sun C; Guo H; Chen S; Lowe S; Yang P; Tian Y; Liu Y; Zhao Q
    J Gastrointest Surg; 2023 Jul; 27(7):1429-1444. PubMed ID: 37231240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of survival nomograms for patients with differentiated thyroid cancer with distant metastases: a SEER Program-based study.
    Ma Q; Chen Z; Fang Y; Wei X; Wang N; Zhou X; Li S; Ying C
    J Endocrinol Invest; 2024 Jan; 47(1):115-129. PubMed ID: 37294407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.